The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...
Belgium’s Deputy Prime Minister, Frank Vandenbroucke, called the EU’s joint health technology assessment a model of European cooperation, improving medicine evaluation, reducing costs, and ...
Rising temperatures and the associated health risks are set to change mortality trends across Europe, with heat-related ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...
Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this ...
Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...
Alnylam awaits FDA decisions on Amvuttra & Fitusiran next month, poised to boost revenue, profitability, and share growth.
With Gilead Sciences' long-acting lenacapavir unlocking a reinvigorated focus on the pre-exposure prophylaxis (PrEP) market ...
Germany’s first foot and mouth disease outbreak in almost 40 years – and the EU’s first in more than a decade – sent ...
The law should list certain chemicals as critical to Europe’s strategic autonomy, copying similar policies for minerals and ...
Biotech giant Biogen Inc (NASDAQ:BIIB) is scheduled to report fourth-quarter earnings on 12 February. The Wall Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback